Li Y, Wu J, Lu Q, et al. Int J Nanomedicine. 2022;17:2559-2575.
The authors have advised that an error was made during the preparation of the Masson trichromatic staining tumor tissue images shown in on page 2570. All the original data was retained and a correct image for the Masson CUR image was selected as a suitable replacement. The correct Figure 7 is as follows.
Figure 7 Continued.
Figure 7 In vivo antitumor activity in “SP+m-HSCs+H22” tumor-bearing mice. (A) Schematic illustration of treatment scheme on mice. (B) Tumor images of mice treated with different drug formulations. (C) The body weight in mice. (D) Tumor growth inhibition curves. (E) Tumor growth inhibition rate. H&E (F), and Masson trichromatic staining (G) analysis of tumor tissues slices. (H) α-SMA immunofluorescence staining (green fluorescence: α-SMA protein). Immunohistochemical assay of PGP9.5 proteins (I) and CD31 proteins (J). Red arrows: CD31 proteins. Scale bar: 50 μm, *P < 0.05, **P < 0.01, ***P < 0.001.
